TSW
RVMD icon

Three Seasons Wealth’s Revolution Medicines RVMD Stock Holding History

Three Seasons Wealth’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
+1,765
New +$258K 0.03% 149

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Three Seasons Wealth's RVMD Position: Q2 2026 in Review

Three Seasons Wealth opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,765 shares worth $331K. The stake represents 0.03% of the portfolio and ranks #149 among its holdings.

689 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Three Seasons Wealth held 1,765 shares of Revolution Medicines worth $331K as of Q2 2026.
  • Revolution Medicines was a new Three Seasons Wealth position in Q2 2026.
  • Revolution Medicines made up 0.03% of Three Seasons Wealth's portfolio in Q2 2026, its #149 holding.
  • 689 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Three Seasons Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.